Table 3.
Characteristic† | Endovascular (N = 47,248) | Surgery (N = 27,307) | P |
---|---|---|---|
SCI | 51 (0.1) | 55 (0.2) | <0.001 |
Age, mean (SD), y | 74.4 (8.7) | 67.5 11.9) | <0.001 |
Female | 8,867 (18.8) | 8,041 (29.5) | <0.001 |
Race‡ | |||
White | 39,345 (84.5) | 21,669 80.8) | <0.001 |
Black | 1,786 (3.8) | 1,119 (4.2) | |
Hispanic | 2,967 (6.4) | 2,140 (8.0) | |
Asian | 1,171 (2.5) | 817 (3.0) | |
Other | 1,322 (2.8) | 1,088 (4.0) | |
Payment source§ | |||
Medicare | 38,719 (82.0) | 17,056 (62.5) | <0.001 |
Medicaid | 923 (2.0) | 1,197 (4.4) | |
Private | 6,802 (14.3) | 8,134 (29.8) | |
Self-pay | 229 (0.5) | 294 (1.1) | |
Other | 574 (1.2) | 624 (2.2) | |
Hypertension | 36,014 (76.2) | 20,028 (73.3) | <0.001 |
Diabetes | 9,441 (20.0) | 5,530 (20.3) | 0.40 |
Coronary heart disease | 22,849 (48.4) | 12,013 (44.0) | <0.001 |
Congestive heart failure | 4,039 (8.6) | 4,477 (16.4) | <0.001 |
Peripheral vascular disease | 11,427 (24.2) | 6,900 (25.3) | 0.001 |
Chronic obstructive pulmonary disease | 13,024 (27.6) | 7,577 (27.8) | 0.60 |
Chronic kidney disease | 5,671 (12.0) | 2,939 (10.8) | <0.001 |
Atrial fibrillation | 6,850 (14.5) | 7,638 (28.0) | <0.001 |
Tobacco use | 13,240 (28.0) | 6,164 (22.6) | <0.001 |
Alcohol use | 9,031 (19.1) | 5,652 (20.7) | <0.001 |
Elixhauser comorbidities,| | mean (SD) | 2.4 (1.5) | 3.0 (1.7) | <0.001 |
Abbreviations: SD, standard deviation
Data do not include cases who underwent combined surgical plus endovascular procedures.
Data are presented as number (%) unless otherwise specified.
Self-reported by patients or their surrogates. Numbers do not sum to group totals because of missing race/ethnicity data in 1.8% of patients.
Numbers do not sum to group totals because of missing payment-source data in <0.01% of patients.
Numbers represent the number of Elixhauser comorbid conditions, which comprise a comprehensive set of 28 comorbidity measures for use with large administrative datasets.